REMDESIVIR vs REPOTRECTINIB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
REMDESIVIR vs REPOTRECTINIB: Safety Overview
| Metric | REMDESIVIR | REPOTRECTINIB |
|---|---|---|
| Total FAERS Reports | 10,501 | 187 |
| Deaths Reported | 2,729 | 27 |
| Death Rate | 26.0% | 14.4% |
| Hospitalizations | 2,556 | 48 |
| Average Patient Age | 61.7 yrs | 60.8 yrs |
| % Female Patients | 39.8% | 61.1% |
| FDA Approval Date | Oct 22, 2020 | Jun 11, 2024 |
| Manufacturer | Gilead Sciences, Inc. | E.R. Squibb & Sons, L.L.C. |
| Route | INTRAVENOUS | ORAL |
| Marketing Status | Prescription | Prescription |